Axsome Therapeutics, Inc.
$185.96
$3.24(1.77%)
Axsome Therapeutics, Inc.
AXSM
$185.96
$3.24(1.77%)
Axsome Therapeutics, Inc.
AXSM
NASDAQ
$185.96
$3.24(1.77%)
Chart
Upcoming Earnings
Next report date
Aug 3, 2026
Report period
Q3 2026
EPS Estimate
$-0.80
Revenue Estimate
$222.39M
Key stats
52-Week Range$185.96
$96.09
$234.29
Market capitalization
$11.41BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
-57.09Basic EPS (TTM)
$-3.69Net income (TTM)
$-183.17MRevenue (TTM)
$638.50MAvg. volume
679.12KBeta (1Y)
0.47Employees
712Market capitalization
$11.41BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
-57.09Basic EPS (TTM)
$-3.69Net income (TTM)
$-183.17MRevenue (TTM)
$638.50MAvg. volume
679.12KBeta (1Y)
0.47Employees
712Screener Quick Check
Sign in to check this stock against your screeners
Sign InAbout Axsome Therapeutics, Inc.
Sector
Healthcare
Industry
Biotechnology
CEO
Herriot Tabuteau
Website
www.axsome.comHeadquarters
22 Cortlandt Street, New York City, NY, 10007
IPO Date
2015-11-19
Identifiers
ISIN
US05464T1043Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous...
Related Stocks
$212.26
1D:
2.0%
1Y:
79.6%
IE00B4Q5ZN47Healthcare
Mkt Cap
$13.32B
P/E Ratio TTM
-34.7
Revenue TTM
$4.27B
Beta
0.23
Earnings TTM
$-356.15M
Dividend Yield TTM
0.00%
$74.93
1D:
-1.9%
1Y:
436.0%
US04280A1007Healthcare
Mkt Cap
$10.49B
P/E Ratio TTM
51.8
Revenue TTM
$1.09B
Beta
1.27
Earnings TTM
$202.27M
Dividend Yield TTM
0.00%
Dividend Overview
This company does not pay dividends
Financials
Performance
Margin trends
Debt level and coverage
Earnings
Next: Q3 '26
Actual
Estimate
Performance
Margin trends
Debt level and coverage
Earnings
Next: Q3 '26
Actual
Estimate